Naunyn-Schmiedeberg's Archives of Pharmacology

SJR Rank #6,010H-index: 104SJR: 0.877Best quartile: Q2APC: US$4,790
Journal website: aims, scope and author guidelines
Publisher

Springer Science and Business Media Deutschland GmbH

Country

Germany

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Medicine (miscellaneous)Q2
  • PharmacologyQ2

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Receptor Mechanisms and SignalingNeuroscience and Neuropharmacology ResearchIon channel regulation and functionBiomedical and Chemical ResearchNeuropeptides and Animal PhysiologyNeurotransmitter Receptor Influence on BehaviorNitric Oxide and Endothelin EffectsCardiac electrophysiology and arrhythmiasPain Mechanisms and TreatmentsMetabolism and Genetic Disorders

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs035070010501400

Documents per Year

20222025035070010501400

Detailed Information

ISSN

0028-1298, 1432-1912

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

4.73

References per Document

77.44

Coverage

1969-2026

Scope

Naunyn-Schmiedeberg's Archives of Pharmacology was founded in 1873 by B. Naunyn, O. Schmiedeberg and E. Klebs as Archiv für experimentelle Pathologie und Pharmakologie, is the offical journal of the German Society of Experimental and Clinical Pharmacology and Toxicology (Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, DGPT) and the Sphingolipid Club. The journal publishes invited reviews, original articles, short communications and meeting reports and appears monthly. Naunyn-Schmiedeberg's Archives of Pharmacology welcomes manuscripts for consideration of publication that report new and significant information on drug action and toxicity of chemical compounds. Thus, its scope covers all fields of experimental and clinical pharmacology as well as toxicology and includes studies in the fields of neuropharmacology and cardiovascular pharmacology as well as those describing drug actions at the cellular, biochemical and molecular levels. Moreover, submission of clinical trials with healthy volunteers or patients is encouraged. Short communications provide a means for rapid publication of significant findings of current interest that represent a conceptual advance in the field.

Metrics from SCImago Journal Rank 2025. View on SCImago